Search Orphan Drug Designations and Approvals
-
Generic Name: | Ulixertinib |
---|---|
Date Designated: | 06/24/2013 |
Orphan Designation: | Treatment of Stage IIb through Stage IV BRAF mutant melanoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
BioMed Valley Discoveries, Inc. 4435 Main Street Suite 550 Kansas City, Missouri 64111 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-